Abuse-deterrent Formulations

Low Potential for Abuse With Extended-Release Oxycodone

Low Potential for Abuse With Extended-Release Oxycodone

By

An abuse liability assessment was conducted to determine the abuse potential and pharmacokinetics of extended-release vs immediate-release oxycodone.

Extended-Release Oxycodone Efficacious for Chronic Low Back Pain

Extended-Release Oxycodone Efficacious for Chronic Low Back Pain

By

Abuse-deterrent extended-release oxycodone (Xtampza® ER; Collegium Pharmaceutical) provided adequate pain relief for patients with chronic low back pain who were previously receiving immediate-release oxycodone.

Abuse-Deterrent Opioids Might Not Be the Answer to the Opioid Crisis

Abuse-Deterrent Opioids Might Not Be the Answer to the Opioid Crisis

By

Abuse-deterrent opioid formulations may not be the most effective solution to the opioid crisis, according to an editorial published in the New England Journal of Medicine.

Sign Up for Free e-Newsletters